Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (252 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 02 Jan 2013 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | SBI ESG Exclusionary Strategy Fund |
|---|---|
| 02 Jan 2013 | ₹100.00 |
| 21 Feb 2014 | ₹103.12 |
| 12 Apr 2015 | ₹162.58 |
| 31 May 2016 | ₹161.03 |
| 19 Jul 2017 | ₹194.60 |
| 07 Sep 2018 | ₹222.88 |
| 27 Oct 2019 | ₹236.50 |
| 15 Dec 2020 | ₹273.41 |
| 03 Feb 2022 | ₹368.10 |
| 25 Mar 2023 | ₹345.82 |
| 12 May 2024 | ₹470.15 |
| 01 Jul 2025 | ₹546.73 |
| 20 Aug 2026 | ₹549.97 |
| Metric | SBI · Direct NAV ₹266.74 Very High risk ★★☆☆☆ | Category median Sectoral/ Thematic · 252 funds |
|---|---|---|
| +1.86% | +7.23% | |
| +11.32% | +16.94% | |
| +10.14% | +14.70% | |
| +12.12% | +15.10% | |
| +13.32% | +14.07% | |
| +9.38% | — | |
| +14.16% | +17.59% | |
| +14.06% | +16.29% | |
| +13.97% | +16.00% | |
| Risk | ||
| 13.11% | 15.69% | |
| 0.37 | 0.52 | |
| 0.51 | 0.73 | |
| -36.66% | -23.08% | |
| Nifty 500 | — | |
| -0.48% | +4.66% | |
| 0.92 | 0.96 | |
| 90.3% | 109.1% | |
| 89.0% | 91.0% | |
| 1.38% | 1.14% | |
| ₹4,732Cr | ₹1,161Cr | |
| 1.00% | — | |
| None | — | |
| ₹500 | — | |
| ₹1.00K | — | |
| 56% | 45% | |
| Rohit Shimpi | — | |
| 02 Jan 2013 | — | |
| 42 | — | |
| 48.8% | — | |
| 3.7% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.